Aquestive Therapeutics files February 2026 investor presentation without new financial data

Aquestive Therapeutics, Inc.

Presentation furnished under Regulation FD; intended for meetings with institutional investors.
Only a title slide was provided in the exhibit; no specific financial figures or guidance.
No updates to product pipeline, revenue, or strategic initiatives were disclosed.
Ticker AQST continues to trade on Nasdaq; corporate address unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.